Quantitative iTRAQ LC-MS/MS proteomics reveals transcription factor crosstalk and regulatory networks in hypopharyngeal squamous cell carcinoma

Journal of Cancer

Volumn 5, Issue 7, 2014, Pages 525-536

  Zhu, Gangcai ^a,b   Cai, Gengming ^c   Liu, Yong ^a,b   Tan, Haolei ^a,b   Yu, Changyun ^a,b   Huang, Meiling ^a,b   Wei, Ming ^a,b   Li, She ^a,b   Cui, Xiangning ^a,b   Huang, Donghai ^a,b   Tian, Yongquan ^a,b   Zhang, Xin ^a,b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Otolaryngology Major Disease Research Key Laboratory of Hunan Province   (China)

^c FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

Carcinogenesis; Hypopharyngeal squamous cell carcinoma; ITRAQ; Metastasis; Proteomics analysis; Transcription factor network

Indexed keywords

ALPHA6BETA4 INTEGRIN; BIOLOGICAL MARKER; CASPASE 7; EPIDERMAL GROWTH FACTOR RECEPTOR; GELATINASE A; INTEGRIN; PROTEIN; PROTEIN MDM2; PROTEIN P53; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; TRANSCRIPTION FACTOR;

ACTIN FILAMENT; ADULT; ARTICLE; CANCER STAGING; CARCINOGENESIS; HUMAN; HUMAN TISSUE; HYPOPHARYNX CANCER; HYPOPHARYNX SQUAMOUS CELL CARCINOMA; LIQUID CHROMATOGRAPHY; LYMPH NODE METASTASIS; METASTASIS; ONCOGENE C MYC; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SMOKING; SQUAMOUS CELL CARCINOMA; TANDEM MASS SPECTROMETRY; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

EID: 84902976293     PISSN: None     EISSN: 18379664     Source Type: Journal    
DOI: 10.7150/jca.9207     Document Type: Article

References (44)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012; 62(1):10-29.
2. Braakhuis BJ, Senft A, et al. Expression profiling and prediction of distant metastases in head and neck squamous cell carcinoma. J Clin Pathol. 2006; 59(12): 1254-1260.
3. Schaaij-Visse, TB, BrakenhoffRH, Leemans CR, et al. Protein biomarker discovery for head and neck cancer. J Proteomics. 2010; 73(10): 1790-1803.
4. Vandecaveye, V., De Keyzer, F., Vander, P. V. et al. Head and neck squamous cell carcinoma: value of diffusion-weighted mr imaging for nodal staging. Radiology. 2009; 251(1):134-146.
5. Hayashi J, Sakata KI, Someya M, et al. Analysis and results of ku and xrcc4 expression in hypopharyngeal cancer tissues treated with chemoradiotherapy. Oncol Lett. 2012; 4(1): 151-155.
6. Sepiashvili L, Hui A, Ignatchenko V, et al. Potentially novel candidate biomarkers for head and neck squamous cell carcinoma identified using an integrated cell line-based discovery strategy. Mol Cell Proteomics. 2012; 11(11): 1404-1415.
7. Feng Z, Xu Q, Chen W. Epigenetic and genetic alterations-based molecular classification of head and neck cancer. Expert Rev Mol Diagn. 2012; 12(3):279-290.
8. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011; 144(5): 646-674.
9. Zhang XP, Yin XF, Yu HH, et al. Quantitative proteomic analysis of serum proteins in patients with parkinson's disease using an isobaric tag for relative and absolute quantification labeling, two-dimensional liquid chromatography, and tandem mass spectrometry. ANALYST. 2012; 137(2): 490-495.
10. Wu D, Zhu D, Xu M, et al. Analysis of transcriptional factors and regulation networks in patients with acute renal allograft rejection. J Proteome Res. 2011; 10(1): 175-181.
11. Cai GM, Huang DH, Dai YZ, et al. Analysis of transcriptional factors and regulation networks in laryngeal squamous cell carcinoma patients with lymph node metastasis. J Proteome Res. 2012; 11(2):1100-1107.
12. Liu Y, Yu C, Qiu Y, et al. Downregulation of epha2 expression suppresses the growth and metastasis in squamous-cell carcinoma of the head and neck in vitro and in vivo. J Cancer Res Clin Oncol. 2012; 138(2): 195-202.
13. Nikolsky Y, Kirillov E, Zuev R, et al. Functional analysis of omics data and small molecule compounds in an integrated "knowledge-based" platform. Methods Mol Biol. 2009; 563:177-196.
14. Severin J, Waterhouse AM, Kawaji H, et al. Fantom4 edgeexpressdb: an integrated database of promoters, genes, micrornas, expression dynamics and regulatory interactions. Genome Biol. 2009; 10(4): R39.
15. de Hoon MJ, Imoto S, Nolan J, et al. Open source clustering software. Bioinformatics. 2004; 20(9):1453-1454.
16. Zhang X, Hunt JL, Landsittel DP, et al. Correlation of protease-activated receptor-1 with differentiation markers in squamous cell carcinoma of the head and neck and its implication in lymph node metastasis. Clin Cancer Res. 2004; 10(24):8451-8459.
17. Zhang F, Tian Q, Wang Y. Far upstream element-binding protein 1 (fubp1) is overexpressed in human gastric cancer tissue compared to non-cancerous tissue. Onkologie. 2013; 36(11b): 650-655.
18. Khatri P, Sirota M, Butte AJ. Ten years of pathway analysis: current approaches and outstanding challenges. PLoS Comput Biol. 2012; 8(2e):1002375.
19. Huang Q, Yu GP, Mccormick SA, et al. Genetic differences detected by comparative genomic hybridization in head and neck squamous cell carcinomas from different tumor sites: construction of oncogenetic trees for tumor progression. Genes Chromosomes Cancer. 2002; 34(2): 224-233.
20. Weinberger PM, Merkley M, Lee JR, et al. Use of combination proteomic analysis to demonstrate molecular similarity of head and neck squamous cell carcinoma arising from different subsites. Arch Otolaryngol Head Neck Surg. 2009; 135(7): 694-703.
21. Lu Q, Bai J, Zhang L, et al. Two-dimensional liquid chromatography-tandem mass spectrometry coupled with isobaric tags for relative and absolute quantification (itraq) labeling approach revealed first proteome profiles of pulmonary alveolar macrophages infected with porcine reproductive and respiratory syndrome virus. J Proteome Res. 2012; 11(5):2890-2903.
22. Jiao Y, Killela PJ, Reitman ZJ, et al. Frequent atrx, cic, and fubp1 mutations refine the classification of malignant gliomas. Oncotarget. 2012; 3(7): 709-722.
23. Bettegowda C, Agrawal N, Jiao Y, et al. Mutations in cic and fubp1 contribute to human oligodendroglioma. Science. 2011; 333(6048): 1453-1455
24. Wang J, Sun Y, Zheng S, et al. Apg: an active protein-gene network model to quantify regulatory signals in complex biological systems. Sci Rep. 2013; 3:1097.
25. Chu S. Transcriptional regulation by post-transcriptional modification--role of phosphorylation in sp1 transcriptional activity. Gene. 2012; 508(1): 1-8.
26. Aslam F, Palumbo L, Augenlicht LH, et al. The sp family of transcription factors in the regulation of the human and mouse muc2 gene promoters. Cancer Res. 2001; 61(2):570-576.
27. Wang F, Li Y, Zhou J, et al. Mir-375 is down-regulated in squamous cervical cancer and inhibits cell migration and invasion via targeting transcription factor sp1. Am J Pathol. 2011; 179(5):2580-2588.
28. Yue L, Li L, Liu F, et al. The oncoprotein hbxip activates transcriptional coregulatory protein lmo4 via sp1 to promote proliferation of breast cancer cells. Carcinogenesis. 2013; 34(4):927-935.
29. Huang PH, Wang D, Chuang HC, et al. Alpha-tocopheryl succinate and derivatives mediate the transcriptional repression of androgen receptor in prostate cancer cells by targeting the pp2a-jnk-sp1-signaling axis. Carcinogenesis. 2009; 30(7):1125-1131.
30. Jerhammar F, Ceder R, Garvin S, et al. Fibronectin 1 is a potential biomarker for radioresistance in head and neck squamous cell carcinoma. Cancer Biol Ther. 2010; 10(12): 1244-1251.
31. Zhang X, Su L, Pirani AA, et al. Understanding metastatic scchn cells from unique genotypes to phenotypes with the aid of an animal model and dna microarray analysis. Clin Exp Metastasis. 2006; 23(3-4): 209-222.
32. Brosh R, Rotter V. When mutants gain new powers: news from the mutant p53 field. Nat Rev Cancer. 2009; 9(10):701-713.
33. Wang MJ, Pei DS, Qian GW, et al. P53 regulates ki-67 promoter activity through p53-and sp1-dependent manner in hela cells. Tumour Biol. 2011; 32(5):905-912.
34. Boyle JO, Hakim J, Koch W, et al. The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res. 1993; 53(19): 4477-4480.
35. El-Deiry WS. Regulation of p53 downstream genes. Semin Cancer Biol. 1998; 8(5):345-357.
36. Liu X, Wilcken R, Joerger AC, et al. Small molecule induced reactivation of mutant p53 in cancer cell. Nucleic Acids Res. 2013; 37.
37. Lee SW, Lee MH, Park JH, et al. Sumoylation of hnrnp-k is required for p53-mediated cell-cycle arrest in response to dna damage. EMBO J. 2012; 31(23): 4441-4452.
38. Ohlsson C, Kley N, Werner H, et al. P53 regulates insulin-like growth factor-i (igf-i) receptor expression and igf-i-induced tyrosine phosphorylation in an osteosarcoma cell line: interaction between p53 and sp1. Endocrinology. 1998; 139(3):1101-1107.
39. Levayer R, Lecuit T. Breaking down emt. Nat Cell Biol. 2008; 10(7), 757-759
40. Oster SK, Ho CS, Soucie EL, et al. The myc oncogene: marvelously complex. Adv Cancer Res. 2002; 84:81-154.
41. Xiao Q, Claassen G, Shi J, et al. Transactivation-defective c-mycs retains the ability to regulate proliferation and apoptosis. Genes Dev. 1998; 12(24): 3803-3808.
42. Gartel AL, Shchors K. Mechanisms of c-myc-mediated transcriptional repression of growth arrest genes. Exp Cell Res. 2003; 283(1):17-21.
43. Frederick MJ, Holton PR, Hudson M, et al. Expression of apoptosis-related genes in human head and neck squamous cell carcinomas undergoing p53-mediated programmed cell death. Clin Cancer Res. 1999; 5(2):361-369.
44. Zawacka-Pankau J, Grinkevich VV, Hunten S, et al. Inhibition of glycolytic enzymes mediated by pharmacologically activated p53: targeting warburg effect to fight cancer. J Biol Chem. 2011; 286(48): 41600-41615.